Necrosectomy Study

Prospective, Trial Evaluating the Safety and Effectiveness of the Interscope EndoRotor® Resection System for Direct Endoscopic Necrosectomy of Walled off Pancreatic Necrosis (EndoRotor Den Trial)

Protocol # CLIN 0047, Revision D, (31 August 2018)
US FDA IDE # G180127
NCT 03694210

Barrett’s Study

Prospective, Randomized Trial Comparing the Safety and Effectiveness of the Interscope EndoRotor Mucosal Resection System with Continued Ablative Therapy in Subjects with Refractory Dysplastic Barrett’s Esophagus

Protocol # CLIN 0010, Revision F, (07 February 2019)
US FDA IDE # G170106
NCT 03364114

EndoRotor - Low Grade Squamous Cell Carcinoma (SCC)

EndoRotor is not yet approved for sale for primary resection of SCC. Current clinical trials are enrolling refractory Barrett’s Esophagus patients.

 

Colon Study

Prospective, Multicenter Study for the Evaluation of Safety and Performance of the Interscope EndoRotor Endoscopic Mucosal Resection System for the Removal of Alimentary Tract Mucosa in the Colon

Protocol # CLIN 0001
Revision E (27 July 2018)